Our Sciences

- R&D Based portfolio.
- Clinical Trials conducted in reference countries by key globally recognized investigators.
- Evidence Generation in key International centers: Phase II, III and Phase IV.
- Formulation development in the US, Europe and Israel.
- Therapeutic Areas: Pain, CNS, Cancer.
- First to market technology.
- Unique Sciences, MOA, and delivery Systems.
- Extensive Scientific Network.